Sumit Verma currently serves as Vice President Commercial Manufacturing for Iovance Biotherapeutics – A San Francisco based Immuno-Oncology company dedicated to providing novel products for curing cancer. He has executive responsibilities for building a new pharmaceutical manufacturing facility and commercial manufacturing organization that will be involved in providing life-saving cancer therapies across North America and Europe.
Prior to Iovance, he has had multiple leadership roles at Merck, Covidien, Mallinckrodt and most recently served as the Chief Operating Officer for Curium Pharmaceuticals. He has successfully led his respective teams in four new FDA-approved drug launches over the past 10 years.
Sumit received his Bachelor of Science in Chemical Engineering from Lafayette College and Master’s in Engineering Management from Washington University in St. Louis and is fluent in 4 languages. He is a certified PMP® professional, has a Six Sigma Black belt and holds 13 U.S patents in pharmaceutical technology and drug development.